kabutan

Human Metabolome Technologies, Inc.(6090) Summary

6090
TSE Standard
Human Metabolome Technologies, Inc.
690
JPY
0
(0.00%)
Jan 29, 2:07 pm JST
4.51
USD
Jan 29, 12:07 am EST
Result
PTS
outside of trading hours
682
Jan 29, 1:21 pm JST
Summary Chart Historical News Financial Result
PER
14.9
PBR
2.30
Yield
2.61%
Margin Trading Ratio
Stock Price
Jan 29, 2026
Opening Jan 29, 9:00 am
697 JPY 4.55 USD
Previous Close Jan 28
690 JPY 4.52 USD
High Jan 29, 9:06 am
698 JPY 4.55 USD
Low Jan 29, 1:08 pm
679 JPY 4.43 USD
Volume
7,200
Trading Value
5.00M JPY 0.03M USD
VWAP
688.33 JPY 4.5 USD
Minimum Trading Value
69,000 JPY 451 USD
Market Cap
4.08B JPY 0.03B USD
Number of Trades
36
Liquidity & Number of Trades
As of Jan 29, 2026
Liquidity
Slightly Low
1-Year Average
37
1-Year High Jul 1, 2025
282
Margin Trading
Date Short Interest Long Margin Positions Ratio
Jan 23, 2026 0 218,800
Jan 16, 2026 0 218,800
Jan 9, 2026 0 218,200
Dec 26, 2025 0 224,600
Dec 19, 2025 0 223,700
Company Profile
Human Metabolome Technologies, Inc. is a biotech venture company originating from Keio University. The company specializes in metabolite analysis services and biomarker detection.
Sector
Services
Human Metabolome Technologies develops businesses utilizing metabolome analysis and biotechnology. Through its comprehensive metabolite analysis technology using CE-MS method, the company engages in two main business areas: advanced research and development support, and healthcare solutions. In the former, the company provides metabolome analysis services to food, chemical, and pharmaceutical companies, as well as research institutions. In the latter, it supports the development of functional materials.